Shareholders' Equity and Capital Stock - Schedule of outstanding RSUs (Details) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Shareholders Equity and Capital Stock | |||
| Number of RSUs | 1,127,706 | 1,069,645 | 641,910 |
| Weighted-Average Remaining contractual life (years) | 1 year 6 months | ||
| Aggregate Fair Value | $ 1,567,511 | ||
| 2026-12-12 | |||
| Shareholders Equity and Capital Stock | |||
| Number of RSUs | 476,101 | ||
| Weighted-Average Remaining contractual life (years) | 10 months 24 days | ||
| Aggregate Fair Value | $ 661,780 | ||
| Vesting Date | Dec. 12, 2026 | ||
| 2027-12-22 | |||
| Shareholders Equity and Capital Stock | |||
| Number of RSUs | 651,605 | ||
| Weighted-Average Remaining contractual life (years) | 2 years | ||
| Aggregate Fair Value | $ 905,731 | ||
| Vesting Date | Dec. 22, 2027 |
| X | ||||||||||
- Definition Aggregate fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Date when the awards are vested under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|